SUBSCRIBERS
Mega deals morph into mega problems for Wall Street
Tie-ups that consolidate industries, move tax dollars offshore have been met with antitrust, legal challenges
Add BT as a preferred sourcePublished Thu, Apr 7, 2016 · 09:50 PM
DeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
IF 2015 was a dream year for Wall Street's top dealmakers, 2016 is starting to take a nightmarish turn.
Some of the mega transactions that had champagne corks popping in boardrooms are running into antitrust problems and, in the case of pharmaceutical firm Pfizer's US$160 billion takeover of rival Allergan PLC, political opposition to a deal that envisaged the biggest drug company in the United States moving to Ireland to lower its taxes.
Share with us your feedback on BT's products and services
